Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-054352

Chief Operating Officer acquired 32,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nabulsi Azmi Chief Operating Officer 2023-11-01 Grant or award +32,500 242,067 D
Loading xslF345X05/doc4.xml…